Literature DB >> 2726722

Potent antibacterial fluoroquinolones with marked activity against Leishmania donovani in vivo.

W Raether1, H Seidenath, J Hofmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2726722     DOI： 10.1007/bf00931138

Source DB:  PubMed          Journal:  Parasitol Res        ISSN： 0932-0113            Impact factor:   2.289


× No keyword cloud information.
  12 in total

Review 1.  DNA topoisomerases.

Authors:  J C Wang
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

2.  Inhibitors of trypanosome topoisomerases.

Authors:  G Riou; S Douc-Rasy; A Kayser
Journal:  Biochem Soc Trans       Date:  1986-04       Impact factor: 5.407

3.  Stable amplified DNA in drug-resistant Leishmania exists as extrachromosomal circles.

Authors:  E P Garvey; D V Santi
Journal:  Science       Date:  1986-08-01       Impact factor: 47.728

4.  Ciprofloxacin and malaria.

Authors:  S Krishna; T M Davis; P C Chan; R A Wells; K J Robson
Journal:  Lancet       Date:  1988-05-28       Impact factor: 79.321

5.  Quinolones and multiresistant Plasmodium falciparum.

Authors:  J M Midgley; D W Keter; J D Phillipson; S Grant; D C Warhurst
Journal:  Lancet       Date:  1988-07-30       Impact factor: 79.321

6.  Limited activity of bacterial DNA topoisomerase II inhibitors against Leishmania donovani and Trypanosoma cruzi amastigotes in vitro.

Authors:  S L Croft; J Hogg
Journal:  Trans R Soc Trop Med Hyg       Date:  1988       Impact factor: 2.184

Review 7.  DNA topoisomerases.

Authors:  M Gellert
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

8.  Bacterial chromosome segregation: evidence for DNA gyrase involvement in decatenation.

Authors:  T R Steck; K Drlica
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

9.  DNA topoisomerase II mutant of Saccharomyces cerevisiae: topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication.

Authors:  S DiNardo; K Voelkel; R Sternglanz
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

10.  Novobiocin antagonism of amastigotes of Trypanosoma cruzi growing in cell-free medium.

Authors:  P G Pate; J S Wolfson; G L McHugh; S C Pan; M N Swartz
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191
View more
  6 in total

1.  Antitrypanosomal activity of fluoroquinolones.

Authors:  E Nenortas; C Burri; T A Shapiro
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

Review 2.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

3.  Canine leishmaniosis: in vitro efficacy of miltefosine and marbofloxacin alone or in combination with allopurinol against clinical strains of Leishmania infantum.

Authors:  Anna Maria Farca; B Miniscalco; P Badino; R Odore; P Monticelli; A Trisciuoglio; E Ferroglio
Journal:  Parasitol Res       Date:  2012-01-05       Impact factor: 2.289

4.  The efficacy of enrofloxacin, alone or combined with metronidazole, in the therapy of canine leishmaniasis.

Authors:  Paolo Bianciardi; Antonio Fasanella; Valentina Foglia Manzillo; Teresa Trotta; Annalisa Pagano; Simona Sorino; Luigi Gradoni; Gaetano Oliva
Journal:  Parasitol Res       Date:  2004-07-23       Impact factor: 2.289

Review 5.  Newly documented antimicrobial activity of quinolones.

Authors:  Y X Furet; J C Pechère
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

Review 6.  Antiviral, antifungal, and antiparasitic activities of fluoroquinolones optimized for treatment of bacterial infections: a puzzling paradox or a logical consequence of their mode of action?

Authors:  A Dalhoff
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-12-17       Impact factor: 3.267
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.